反応式
[N:1]([CH2:4][C:5]([N:7]1[CH2:12][CH2:11][O:10][CH:9]([C:13]([O:15][CH2:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)=[O:14])[CH2:8]1)=[O:6])=[N+:2]=[N-:3].O.O=[C:25]1O[C@H:30]([C@H:32](CO)O)[C:28]([O-])=[C:26]1O.[Na+].C#CCCC>CC(O)(C)C.CCOC(C)=O.O.O.O.O.O.S([O-])([O-])(=O)=O.[Cu+2]>[CH2:28]([C:26]1[N:3]=[N:2][N:1]([CH2:4][C:5]([N:7]2[CH2:12][CH2:11][O:10][CH:9]([C:13]([O:15][CH2:16][C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)=[O:14])[CH2:8]2)=[O:6])[CH:25]=1)[CH2:30][CH3:32]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
In a sealable vessel, benzyl 4-(2-azidoacetyl)morpholine-2-carboxylate (0.096 g, 0.32 mmol) was suspended in t-BuOH (1 mL) and water (1 mL) was added. An aqueous solution of sodium ascorbate (1.0 M, 0.032 ml, 0.032 mmol) and an aqueous solution of copper(II) sulfate pentahydrate (0.30 M, 0.079 ml, 0.024 mmol) were added, followed by pent-1-yne (0.040 ml, 0.41 mmol). The vessel was sealed and placed in a 65 deg oil bath, whereupon the mixture was stirred for 14 h. The reaction mixture was cooled to RT, taken up in EtOAc (60 mL), and the organic layer was extracted with dilute sodium bicarbonate (5 mL), dilute brine (5 mL), and saturated brine (5 mL), then was dried over sodium sulfate and concentrated. The residue was purified through silica gel (25 mL) eluting with EtOAc, affording the title compound (105 mg, 0.28 mmol). MS m/z 373 (M+1).
後処理
- customThe vessel was sealed
- customplaced in a 65 deg
- extractionthe organic layer was extracted with dilute sodium bicarbonate (5 mL), dilute brine (5 mL), and saturated brine (5 mL)
- dry with materialwas dried over sodium sulfate
- concentrationconcentrated
- customThe residue was purified through silica gel (25 mL)
- washeluting with EtOAc
出典と根拠
- ORDレコード
- ord-faeb4f8a57de4cb992633bfb8d63a567
- 出典データセット
- uspto-grants-2011_01
- 特許番号
- US07872009B2
関連ノート
読み込み中…